Ukko raises $40 million to address food allergies with AI
January 27, 2021
Ukko, a 30-employee biotech company using AI to investigate solutions for food allergies and sensitivities, today raised $40 million in a series B round led by Bayer’s Leaps by Bayer. Ukko says the new funding will allow it to enter clinical trials with an investigational therapeutic for peanut allergies while accelerating development of its synthetic gluten for people with celiac and other…